Berney T et al. |
Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations. |
2004 |
Transplant. Proc. |
pmid:15194390
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Weng LC et al. |
Association between use of FK506 and prevalence of post-transplantation diabetes mellitus in kidney transplant patients. |
2014 |
Transplant. Proc. |
pmid:24656004
|
Wang SS et al. |
Clinical experience of tacrolimus with everolimus in heart transplantation. |
2012 |
Transplant. Proc. |
pmid:22564581
|
Zeevi A et al. |
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689884
|
Latorre A et al. |
Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959186
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Shapiro R et al. |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636557
|
González E et al. |
Everolimus represents an advance in immunosuppression for patients who have developed cancer after renal transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715911
|
Burke GW et al. |
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. |
1998 |
Transplant. Proc. |
pmid:9532223
|
Ochiai M et al. |
Islet toxicity of FK506 measured in canine autografts. |
1998 |
Transplant. Proc. |
pmid:9532224
|
Klintmalm GB et al. |
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679840
|
Ericzon BG et al. |
Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721273
|
Ye Q et al. |
Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. |
1996 |
Transplant. Proc. |
pmid:8623350
|
Gentil MA et al. |
Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression. |
2005 |
Transplant. Proc. |
pmid:15866631
|
Shimizu T et al. |
Risk factors of acute tacrolimus nephrotoxicity in renal allografts. |
2000 |
Transplant. Proc. |
pmid:11119998
|
Garcia-Donaire JA et al. |
Tacrolimus as basic immunosuppression in pregnancy after renal transplantation. A single-center experience. |
2005 |
Transplant. Proc. |
pmid:16386528
|
Argudo A et al. |
Liver Transplant Patient Carriers of Polymorphism Cyp3a5*1 Donors May Need More Doses of Tacrolimus From the First Month After Transplantation. |
2015 |
Transplant. Proc. |
pmid:26518936
|
Cuñetti L et al. |
Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay. |
2018 |
Transplant. Proc. |
pmid:29579828
|
Tarasewicz A et al. |
Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex. |
2009 |
Transplant. Proc. |
pmid:19917366
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Donnelly JG and Soldin SJ |
Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721305
|
Kawauchi M et al. |
Cardiac xenotransplantation from pig to Japanese monkey with splenectomy, tacrolims, filtration plasmapheresis, and nafamstat mesilate. |
1994 |
Transplant. Proc. |
pmid:7518105
|
Falkiewicz K et al. |
Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. |
2005 |
Transplant. Proc. |
pmid:15848611
|
Oppenheimer F |
Steroid withdrawal in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10686314
|
Platz KP et al. |
OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. |
1995 |
Transplant. Proc. |
pmid:7533357
|
Hairhara Y et al. |
Effect of fluconazole on blood levels of tacrolimus. |
1999 |
Transplant. Proc. |
pmid:10578284
|
Kantarci G et al. |
Effects of different calcineurin inhibitors on sex hormone levels in transplanted male patients. |
2004 Jan-Feb |
Transplant. Proc. |
pmid:15013339
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Kolonko A et al. |
Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation. |
2011 |
Transplant. Proc. |
pmid:21996198
|
Abu-Elmagd K et al. |
Management of intestinal transplantation in humans. |
1992 |
Transplant. Proc. |
pmid:1376523
|
Takaori K et al. |
Basic study on immunologic effects of cyclosporine and FK 506 for application to pancreatic transplantation. |
1992 |
Transplant. Proc. |
pmid:1376531
|
Woodle ES et al. |
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721337
|
Shaw BW et al. |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. |
1991 |
Transplant. Proc. |
pmid:1721338
|
Wilson C et al. |
Evaluation of daclizumab to reduce delayed graft function in non-heart-beating renal transplantation: a prospective, randomized trial. |
2005 |
Transplant. Proc. |
pmid:15919462
|
Weimer R et al. |
sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. |
2005 |
Transplant. Proc. |
pmid:15919463
|
Kawano K et al. |
Protective effect of FK 506 on hepatic injury following cold ischemic preservation and transplantation: influence on hepatic microcirculation. |
1995 |
Transplant. Proc. |
pmid:7533410
|
Viganò J et al. |
The role of basiliximab induction therapy in adult-to-adult living-related transplantation and deceased donor liver transplantation: a comparative retrospective analysis of a single-center series. |
2008 Jul-Aug |
Transplant. Proc. |
pmid:18675099
|
Varo E et al. |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. |
2002 |
Transplant. Proc. |
pmid:12176481
|
de Oliveira Clark RM et al. |
Evaluation of hemodynamic, metabolic, and electrolytic changes after graft reperfusion in a porcine model of intestinal transplantation. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172287
|
Larriba J et al. |
Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172323
|
Cicero A and Lappin JA |
Pancreas transplantation: experience at University of Texas, Houston. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172339
|
Odoul F et al. |
Massive ingestion of tacrolimus in a young liver transplant patient. |
1998 |
Transplant. Proc. |
pmid:9865375
|
Cronin DC et al. |
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123010
|
Rossi G et al. |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907932
|
Platz KP et al. |
Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8907933
|
Todo S et al. |
Clinical small bowel or small bowel plus liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721369
|
Tzakis AG et al. |
Use of FK 506 in pediatric patients. |
1991 |
Transplant. Proc. |
pmid:1703353
|
|
Morphopathological findings of renal allografts under FK 506 therapy. Japanese FK 506 Study Group. |
1994 |
Transplant. Proc. |
pmid:7520614
|
Imanishi M et al. |
Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model. |
1994 |
Transplant. Proc. |
pmid:7520615
|
Mange KC and Bloom RD |
Rates of acute rejection by recipient race and type of calcineurin inhibitor with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12493393
|
Domenech N et al. |
Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients. |
2003 |
Transplant. Proc. |
pmid:12962873
|
Wayman MR et al. |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy. |
2002 |
Transplant. Proc. |
pmid:12176526
|
Sahutoglu T et al. |
Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation. |
2017 |
Transplant. Proc. |
pmid:28340811
|
Marcus EA et al. |
Successful term pregnancy in an intestine-pancreas transplant recipient with chronic graft dysfunction and parenteral nutrition dependence: a case report. |
2015 |
Transplant. Proc. |
pmid:25724255
|
Kaufman DB et al. |
Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083261
|
San Miguel C et al. |
Immunosuppression Strategies in the Treatment of Hepatocellular Carcinoma in Virgen de las Nieves University Hospital. |
2015 |
Transplant. Proc. |
pmid:26518930
|
Miura K et al. |
Development of the Intestinal Transplantation Model With Major Histocompatibility Complex Inbred CLAWN Miniature Swine. |
2016 |
Transplant. Proc. |
pmid:27320612
|
Guo Z et al. |
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123314
|
Jiang Y et al. |
Dyslipidemia in human kidney transplant recipients receiving cyclosporine and tacrolimus is associated with different expression of CD36 on peripheral blood monocytes. |
2011 |
Transplant. Proc. |
pmid:21693242
|
DiMartini A et al. |
Psychiatric morbidity in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721399
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Lopez OL et al. |
Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721400
|
Moutabarrik A et al. |
Effect of FK 506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytes. |
1993 |
Transplant. Proc. |
pmid:7685949
|
Ochiai T et al. |
Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. |
1989 |
Transplant. Proc. |
pmid:2468228
|
Takaya S et al. |
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. |
1993 |
Transplant. Proc. |
pmid:7685953
|
Masaki Y et al. |
Microchimerism and rat small bowel transplantation combined with donor-type bone marrow cells. |
1996 |
Transplant. Proc. |
pmid:8769154
|
Yasunami Y et al. |
Effects of a novel immunosuppressive agent, FK-506, on islet allograft survival in the rat. |
1989 |
Transplant. Proc. |
pmid:2468234
|
Schweizer RT and Meisterling LD |
Tolerability of mycophenolate mofetil in organ transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377540
|
Bhagavati S et al. |
Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports. |
2007 |
Transplant. Proc. |
pmid:18089409
|
Pham SM et al. |
Sirolimus and tacrolimus in clinical cardiac transplantation. |
2002 |
Transplant. Proc. |
pmid:12176597
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Uber PA et al. |
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. |
2002 |
Transplant. Proc. |
pmid:12176598
|
Ciancio G et al. |
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267169
|
Vincenti F |
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267172
|
Alberti D et al. |
Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723310
|
Gridelli B et al. |
Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723311
|
Lagget M et al. |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. |
1998 |
Transplant. Proc. |
pmid:9723312
|
Joo DJ et al. |
Comparison of the affinity column-mediated immunoassay and microparticle enzyme immunoassay methods as a tacrolimus concentration assay in the early period after liver transplantation. |
2010 |
Transplant. Proc. |
pmid:21168645
|
Valdivia LA et al. |
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721432
|
Kawano K et al. |
FK506 reduces oxidative hepatic injury following cold ischemic preservation and transplantation. |
1996 |
Transplant. Proc. |
pmid:8658938
|
Ochiai T et al. |
Prolongation of canine renal allograft survival by treatment with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445075
|
Koc-Zorawska E et al. |
Vascular adhesion protein-1, a novel molecule, in kidney and heart allograft recipients. |
2013 |
Transplant. Proc. |
pmid:23769096
|
Filler G et al. |
Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. |
2004 |
Transplant. Proc. |
pmid:15251324
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
GarcÃa González M et al. |
Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500620
|
Hirata Y et al. |
Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience. |
|
Transplant. Proc. |
pmid:29407332
|
Falconer SJ et al. |
Early or Late Conversion From Tac-BD to Tac-BD in Renal Transplantation: When is the Right Time? |
|
Transplant. Proc. |
pmid:26293044
|
Nossal GJ |
Summary of the First International FK 506 Congress: perspectives and prospects. |
1991 |
Transplant. Proc. |
pmid:1721464
|
Sessa A et al. |
Cardiovascular risk factors in renal transplant patients after switch from standard tacrolimus to prolonged-release tacrolimus. |
2012 |
Transplant. Proc. |
pmid:22974866
|
Haba T et al. |
Pathological and immunohistochemical examination in the rat treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1714649
|
Bozkaya G et al. |
Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients. |
2008 Jan-Feb |
Transplant. Proc. |
pmid:18261573
|
Alagoz S et al. |
Gangliocytoma Presenting With Tacrolimus Neurotoxicity in a Renal Transplant Recipient: Case Report. |
2016 |
Transplant. Proc. |
pmid:27932167
|
Kinukawa T et al. |
Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor. |
1998 |
Transplant. Proc. |
pmid:9636498
|
Alak AM and Moy S |
Biological activity of tacrolimus (FK506) and its metabolites from whole blood of kidney transplant patients. |
1997 |
Transplant. Proc. |
pmid:9270821
|
Deleuze S et al. |
New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine? |
2006 |
Transplant. Proc. |
pmid:16980075
|
Badiou S et al. |
Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? |
2006 |
Transplant. Proc. |
pmid:16980076
|
Flavin T et al. |
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts. |
1991 |
Transplant. Proc. |
pmid:1703701
|
Nielsen FT et al. |
Nephrotoxity of FK 506: a preliminary study on comparative aspects of FK 506 and cyclosporine nephrotoxicity. |
1994 |
Transplant. Proc. |
pmid:7527946
|
Jiang H et al. |
Effect of FK 506 on heart allograft survival in highly sensitized recipient rats in comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703702
|